Cargando…

Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation

BACKGROUND: The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Aung, Hnin, Avraam, Eleni, Ashraf, Muhammad, Karim, Nawazish, Kiran, Sidra, Naeem, Muhammed, Mallik, Srikumar, Panchatsharam, Selva, Tsaknis, George, Reddy, Raja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227453/
https://www.ncbi.nlm.nih.gov/pubmed/34249179
http://dx.doi.org/10.2174/1874306402115010023
_version_ 1783712526647689216
author Aung, Hnin
Avraam, Eleni
Ashraf, Muhammad
Karim, Nawazish
Kiran, Sidra
Naeem, Muhammed
Mallik, Srikumar
Panchatsharam, Selva
Tsaknis, George
Reddy, Raja
author_facet Aung, Hnin
Avraam, Eleni
Ashraf, Muhammad
Karim, Nawazish
Kiran, Sidra
Naeem, Muhammed
Mallik, Srikumar
Panchatsharam, Selva
Tsaknis, George
Reddy, Raja
author_sort Aung, Hnin
collection PubMed
description BACKGROUND: The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. METHODS: We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 cases with severe type 1 respiratory failure requiring FiO2 >0.6 who were admitted to our hospital between 12th March and 04th May’20. British Thoracic Society guidelines were followed for identifying patients needing CPAP. Their outcomes were recorded and compared with a similar group of patients who had oxygen as a ceiling of care. Prospectively collected data between 5th May and 7th June’20 in similar but smaller groups of patients was also analyzed. RESULTS: A total of 104 COVID-19 patients with documented Do Not Attempt Resuscitation (DNAR) decision required high fraction of inspired oxygen (FiO2) >0.6(to maintain peripheral oxygen saturation (SpO2)> 92%(SpO2> 88% in COPD patients). Twenty-four patients received CPAP as the ceiling of care, with a mortality rate of 92.5%. The remaining 84 patients who were on oxygen as a ceiling of treatment had 91.7% mortality. Both population groups had a similar number of comorbidities but were less favorable in terms of age in the control group with standard O2 therapy than those who had CPAP support. Overall mortality outcomes from using CPAP therapy did not bring significant mortality benefit (p-value-0.89). CONCLUSION: CPAP did not appear to improve the survival of patients with severe respiratory failure due to COVID-19 related pneumonia and were not suitable for invasive ventilation. Further studies are warranted to adequately inform appropriate management strategies for this group of patients.
format Online
Article
Text
id pubmed-8227453
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-82274532021-07-09 Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation Aung, Hnin Avraam, Eleni Ashraf, Muhammad Karim, Nawazish Kiran, Sidra Naeem, Muhammed Mallik, Srikumar Panchatsharam, Selva Tsaknis, George Reddy, Raja Open Respir Med J Respiratory Medicine BACKGROUND: The optimum management of respiratory failure in patients with coronavirus (COVID-19) infections has been a challenge for physicians across the globe. Many scientific societies have suggested the use of CPAP (continuous positive airway pressure) in severe cases in an effort to reduce invasive ventilation. We investigated mortality outcomes in patients who needed CPAP but were not suitable for invasive ventilation. METHODS: We retrospectively evaluated the mortality outcomes of all consecutive COVID-19 cases with severe type 1 respiratory failure requiring FiO2 >0.6 who were admitted to our hospital between 12th March and 04th May’20. British Thoracic Society guidelines were followed for identifying patients needing CPAP. Their outcomes were recorded and compared with a similar group of patients who had oxygen as a ceiling of care. Prospectively collected data between 5th May and 7th June’20 in similar but smaller groups of patients was also analyzed. RESULTS: A total of 104 COVID-19 patients with documented Do Not Attempt Resuscitation (DNAR) decision required high fraction of inspired oxygen (FiO2) >0.6(to maintain peripheral oxygen saturation (SpO2)> 92%(SpO2> 88% in COPD patients). Twenty-four patients received CPAP as the ceiling of care, with a mortality rate of 92.5%. The remaining 84 patients who were on oxygen as a ceiling of treatment had 91.7% mortality. Both population groups had a similar number of comorbidities but were less favorable in terms of age in the control group with standard O2 therapy than those who had CPAP support. Overall mortality outcomes from using CPAP therapy did not bring significant mortality benefit (p-value-0.89). CONCLUSION: CPAP did not appear to improve the survival of patients with severe respiratory failure due to COVID-19 related pneumonia and were not suitable for invasive ventilation. Further studies are warranted to adequately inform appropriate management strategies for this group of patients. Bentham Science Publishers 2021-06-18 /pmc/articles/PMC8227453/ /pubmed/34249179 http://dx.doi.org/10.2174/1874306402115010023 Text en © 2021 Aung et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Respiratory Medicine
Aung, Hnin
Avraam, Eleni
Ashraf, Muhammad
Karim, Nawazish
Kiran, Sidra
Naeem, Muhammed
Mallik, Srikumar
Panchatsharam, Selva
Tsaknis, George
Reddy, Raja
Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation
title Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation
title_full Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation
title_fullStr Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation
title_full_unstemmed Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation
title_short Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation
title_sort outcomes of continuous positive airway pressure in the management of patients with coronavirus (covid-19) pneumonia who are not suitable for invasive ventilation
topic Respiratory Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227453/
https://www.ncbi.nlm.nih.gov/pubmed/34249179
http://dx.doi.org/10.2174/1874306402115010023
work_keys_str_mv AT aunghnin outcomesofcontinuouspositiveairwaypressureinthemanagementofpatientswithcoronaviruscovid19pneumoniawhoarenotsuitableforinvasiveventilation
AT avraameleni outcomesofcontinuouspositiveairwaypressureinthemanagementofpatientswithcoronaviruscovid19pneumoniawhoarenotsuitableforinvasiveventilation
AT ashrafmuhammad outcomesofcontinuouspositiveairwaypressureinthemanagementofpatientswithcoronaviruscovid19pneumoniawhoarenotsuitableforinvasiveventilation
AT karimnawazish outcomesofcontinuouspositiveairwaypressureinthemanagementofpatientswithcoronaviruscovid19pneumoniawhoarenotsuitableforinvasiveventilation
AT kiransidra outcomesofcontinuouspositiveairwaypressureinthemanagementofpatientswithcoronaviruscovid19pneumoniawhoarenotsuitableforinvasiveventilation
AT naeemmuhammed outcomesofcontinuouspositiveairwaypressureinthemanagementofpatientswithcoronaviruscovid19pneumoniawhoarenotsuitableforinvasiveventilation
AT malliksrikumar outcomesofcontinuouspositiveairwaypressureinthemanagementofpatientswithcoronaviruscovid19pneumoniawhoarenotsuitableforinvasiveventilation
AT panchatsharamselva outcomesofcontinuouspositiveairwaypressureinthemanagementofpatientswithcoronaviruscovid19pneumoniawhoarenotsuitableforinvasiveventilation
AT tsaknisgeorge outcomesofcontinuouspositiveairwaypressureinthemanagementofpatientswithcoronaviruscovid19pneumoniawhoarenotsuitableforinvasiveventilation
AT reddyraja outcomesofcontinuouspositiveairwaypressureinthemanagementofpatientswithcoronaviruscovid19pneumoniawhoarenotsuitableforinvasiveventilation